Overcoming barriers to early disease intervention

doi:10.1038/s41587-020-0550-z

. 2020 Jun;38(6):669-673.

doi: 10.1038/s41587-020-0550-z.

Overcoming barriers to early disease intervention

H Hugo Caicedo^{1

2}, Daniel A Hashimoto^{3

4}, Julio C Caicedo⁵, Alex Pentland⁶, Gary P Pisano⁷

Affiliations

¹ Connection Science, Massachusetts Institute of Technology, Cambridge, MA, USA. caicedo.hugo@gmail.com.
² Corporate Sustainability and Innovation, Harvard University, Cambridge, MA, USA. caicedo.hugo@gmail.com.
³ Department of Surgery, Massachusetts General Hospital, Boston, MA, USA.
⁴ Harvard Medical School, Boston, MA, USA.
⁵ Materials Engineering, Universidad del Valle, Cali, Colombia.
⁶ Connection Science, Massachusetts Institute of Technology, Cambridge, MA, USA.
⁷ Technology and Operations Management, Harvard Business School, Boston, MA, USA.

PMID: 32444852
DOI: 10.1038/s41587-020-0550-z

Overcoming barriers to early disease intervention

H Hugo Caicedo et al. Nat Biotechnol. 2020 Jun.

. 2020 Jun;38(6):669-673.

doi: 10.1038/s41587-020-0550-z.

Authors

H Hugo Caicedo^{1

2}, Daniel A Hashimoto^{3

4}, Julio C Caicedo⁵, Alex Pentland⁶, Gary P Pisano⁷

Affiliations

¹ Connection Science, Massachusetts Institute of Technology, Cambridge, MA, USA. caicedo.hugo@gmail.com.
² Corporate Sustainability and Innovation, Harvard University, Cambridge, MA, USA. caicedo.hugo@gmail.com.
³ Department of Surgery, Massachusetts General Hospital, Boston, MA, USA.
⁴ Harvard Medical School, Boston, MA, USA.
⁵ Materials Engineering, Universidad del Valle, Cali, Colombia.
⁶ Connection Science, Massachusetts Institute of Technology, Cambridge, MA, USA.
⁷ Technology and Operations Management, Harvard Business School, Boston, MA, USA.

PMID: 32444852
DOI: 10.1038/s41587-020-0550-z

No abstract available

PubMed Disclaimer

Cited by

Dynamic Expression of Palmitoylation Regulators across Human Organ Development and Cancers Based on Bioinformatics.
Jia Z, Long D, Yu Y. Jia Z, et al. Curr Issues Mol Biol. 2022 Sep 27;44(10):4472-4489. doi: 10.3390/cimb44100306. Curr Issues Mol Biol. 2022. PMID: 36286021 Free PMC article.
Degradation of sulfamethazine by microbial electrolysis cell with nickel-cobalt co-modified biocathode.
Li Y, Wei Q, Zhao X, Qi Y, Guo M, Liu W. Li Y, et al. Environ Sci Pollut Res Int. 2024 Mar;31(11):16497-16510. doi: 10.1007/s11356-024-32313-1. Epub 2024 Feb 6. Environ Sci Pollut Res Int. 2024. PMID: 38321275
Prioritizing Early Disease Intervention.
Caicedo HH, Darrow JJ, Caicedo JC, Pentland A. Caicedo HH, et al. Ther Innov Regul Sci. 2023 Nov;57(6):1148-1152. doi: 10.1007/s43441-023-00569-3. Epub 2023 Sep 5. Ther Innov Regul Sci. 2023. PMID: 37668879
Bacterial and Protistan Community Variation across the Changjiang Estuary to the Ocean with Multiple Environmental Gradients.
Jiang X, Zhu Z, Wu J, Lian E, Liu D, Yang S, Zhang R. Jiang X, et al. Microorganisms. 2022 May 9;10(5):991. doi: 10.3390/microorganisms10050991. Microorganisms. 2022. PMID: 35630434 Free PMC article.
Diversity Distribution, Driving Factors and Assembly Mechanisms of Free-Living and Particle-Associated Bacterial Communities at a Subtropical Marginal Sea.
Yuan H, Li T, Li H, Wang C, Li L, Lin X, Lin S. Yuan H, et al. Microorganisms. 2021 Nov 27;9(12):2445. doi: 10.3390/microorganisms9122445. Microorganisms. 2021. PMID: 34946047 Free PMC article.

See all "Cited by" articles

References

1. Anonymous. Nat. Biotechnol. 37, 197 (2019).
1. Bluestone, J. A., Herold, K. & Eisenbarth, G. Nature 464, 1293–1300 (2010). - DOI
1. Diabetes Prevention Trial–Type 1 Diabetes Study Group. N. Engl. J. Med. 346, 1685–1691 (2002).
1. Egan, M. F. et al. N. Engl. J. Med. 380, 1408–1420 (2019). - DOI
1. Demongeot, J. et al. Int. J. Mol. Sci. 10, 4437–4473 (2009). - DOI

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Nature Publishing Group

[1] Anonymous. Nat. Biotechnol. 37, 197 (2019).

[2] Anonymous. Nat. Biotechnol. 37, 197 (2019).

[3] Bluestone, J. A., Herold, K. & Eisenbarth, G. Nature 464, 1293–1300 (2010). - DOI

[4] Bluestone, J. A., Herold, K. & Eisenbarth, G. Nature 464, 1293–1300 (2010). - DOI

[5] Diabetes Prevention Trial–Type 1 Diabetes Study Group. N. Engl. J. Med. 346, 1685–1691 (2002).

[6] Diabetes Prevention Trial–Type 1 Diabetes Study Group. N. Engl. J. Med. 346, 1685–1691 (2002).

[7] Egan, M. F. et al. N. Engl. J. Med. 380, 1408–1420 (2019). - DOI

[8] Egan, M. F. et al. N. Engl. J. Med. 380, 1408–1420 (2019). - DOI

[9] Demongeot, J. et al. Int. J. Mol. Sci. 10, 4437–4473 (2009). - DOI

[10] Demongeot, J. et al. Int. J. Mol. Sci. 10, 4437–4473 (2009). - DOI

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Overcoming barriers to early disease intervention

Affiliations

Overcoming barriers to early disease intervention

Authors

Affiliations

Similar articles

Cited by

References

Publication types

MeSH terms

Substances

LinkOut - more resources

Full Text Sources